Key Market Segments:
By Product
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
By Age Group
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
By End User
- Homecare
- Hospitals
- Clinics
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Poland
- Turkey
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market is valued at USD 21.14 billion in 2025 and is projected to reach USD 46.24 billion by 2035, growing at a CAGR of 8.14% during 2026–2035.
Growth is driven by rising awareness of family planning, increasing unintended pregnancies, supportive government initiatives, improved healthcare access, and ongoing innovation in contraceptive drug formulations.
Oral contraceptive pills dominate the market with a 54.83% share in 2025, while injectable contraceptives are the fastest-growing segment due to their long-acting benefits.
North America holds the largest share (39.62% in 2025) due to advanced healthcare infrastructure, high awareness, and strong presence of pharmaceutical companies.
Key challenges include side effects associated with hormonal contraceptives, regulatory complexities, and concerns regarding long-term health impacts.
Get in touch
